Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 87 Intrinsic Value: Projected FCF is $19.17 as of Aug. 16, 2026, which is 646% above its 10-year median of 2.57. GuruFocus rates CSMYF with a GF Score™ of 87/100 and a GF Value™ of $47.75. The stock has 2 warning signs investors should review. Among 341 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks worse than 73.9% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for COSMOS Pharmaceutical's Intrinsic Value: Projected FCF or its related term are showing as below:
CSMYF'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.77 Med: 2.57 Max: 4.21
Current: 1.93
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of COSMOS Pharmaceutical was 4.21. The lowest was 1.77. And the median was 2.57.
CSMYF's Price-to-Projected-FCF is ranked worse than 73.9% of 341
companies
in the Healthcare Providers & Services industry
Industry Median: 1.11
vs CSMYF: 1.93
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
COSMOS Pharmaceutical's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
37.06
/
22.749199056056
=
1.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Intrinsic Value: Projected FCF Related Terms
COSMOS Pharmaceutical Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $19.17 mean?
COSMOS Pharmaceutical (CSMYF) has a Intrinsic Value: Projected FCF of $19.17 as of Aug. 16, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on COSMOS Pharmaceutical and its competitors. This is 646% above median its historical median of 2.57. Over the past decade, COSMOS Pharmaceutical's Intrinsic Value: Projected FCF has ranged from 1.77 to 4.21. According to the industry distribution chart, COSMOS Pharmaceutical ranks #252 out of 341 companies in the Healthcare Providers & Services industry, placing it in the top 73.9%.
Is COSMOS Pharmaceutical's Intrinsic Value: Projected FCF too high?
COSMOS Pharmaceutical's current Intrinsic Value: Projected FCF of $19.17 is 646% above median its 10-year median of 2.57. Over the past 10 years, this metric has ranged from a low of 1.77 to a high of 4.21. The Healthcare Providers & Services industry median Intrinsic Value: Projected FCF is 1.11. COSMOS Pharmaceutical's value of $19.17 is 1627% above this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #252 out of 341 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Intrinsic Value: Projected FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #252 out of 341 companies for Intrinsic Value: Projected FCF. This places COSMOS Pharmaceutical in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 1.11. COSMOS Pharmaceutical's value of $19.17 is 1627% above this benchmark. Historically, COSMOS Pharmaceutical's own Intrinsic Value: Projected FCF has ranged from 1.77 to 4.21 over the past decade. While the company's 10-year median is 2.57 vs. the industry median of 1.11, COSMOS Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.11, based on 341 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Intrinsic Value: Projected FCF of $19.17 is 1627% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Intrinsic Value: Projected FCF is $19.17, which is 646% above median its own 10-year median of 2.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
COSMOS Pharmaceutical (CSMYF) has a current Intrinsic Value: Projected FCF of $19.17. The stock's GF Value™ is $47.75, compared to a current price of $37.06 — trading 22.4% below its estimated fair value. The current Intrinsic Value: Projected FCF is $19.17, which is 646% above median its 10-year median of 2.57 and 1627% above the Healthcare Providers & Services industry median of 1.11. COSMOS Pharmaceutical's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Intrinsic Value: Projected FCF is $19.17 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 22.4% below its estimated GF Value™ of $47.75.
Key valuation signals for CSMYF:
Intrinsic Value: Projected FCF: $19.17 (646% above median its 10-year median of 2.57)
GF Value™: $47.75 vs. price of $37.06 (22.4% below fair value)
Industry Position: 1627% above the Healthcare Providers & Services median (#252 of 341)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
87GF Score
Get the complete analysis for CSMYF
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
